Osimertinib, Third-generation, Irreversible EGFR-TKI, Targeted for EGFRm NSCLC, EGFR Ex19Del mutation, EGFR L858R mutation, CNS metastasis activity,
Sale!
Lucius
Replica: Osimertinib EGFRm NSCLC Ex19Del/L858R
Original price was: $737.00.$578.00Current price is: $578.00.
Osimertinib, Third-generation, Irreversible EGFR-TKI, Targeted for EGFRm NSCLC, EGFR Ex19Del mutation, EGFR L858R mutation, CNS metastasis activity,